Olivier Tournilhac

29PUBLICATIONS
197CO-AUTHORS
Tumour immunologyPredictive and prognostic markersMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 03, 2026
Genomic loss of MLH1/PMS2 loci defines a mismatch repair deficient subgroup in monomorphic epitheliotropic intestinal T-cell lymphoma.

|May 12, 2026
Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.

|Apr 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Federico Erbella, Emmanuel Bachy, Guillaume Cartron

|Oct 07, 2025
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

David Vallois, Edoardo Missiaglia, Luis Veloza

|Aug 04, 2025
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Olivier Tournilhac, Kamal Bouabdallah, Solène Lecolant

Pageof 5

Frequent Collaborators

8 joint publications

Gandhi-Laurent Damaj

7 joint publications

Laurence L de Leval

5 joint publications

Guillaume Cartron

5 joint publications

Eric Durot